[1]郑永征,杨田野,刘光辉,等.Tie1-shRNA对高糖培养的大鼠内皮细胞Tie1的表达的影响[J].福建医药杂志,2021,43(04):122-125.
　ZHENG Yongzheng,YANG Tianye,LIU Guanghui,et al.Effect of Tie1-shRNA on the expression of Tie1 in high glucose cultured rat endothelial cell[J].FUJIAN MEDICAL JOURNAL,2021,43(04):122-125.
点击复制

Tie1-shRNA对高糖培养的大鼠内皮细胞Tie1的表达的影响()
分享到：

《福建医药杂志》[ISSN:1002-2600/CN:35-1071/R]

卷:
43
期数:
2021年04期
页码:
122-125
栏目:
基础研究
出版日期:
2021-08-15

文章信息/Info

Title:
Effect of Tie1-shRNA on the expression of Tie1 in high glucose cultured rat endothelial cell
文章编号:
1002-2600(2021)04-0122-04
作者:
郑永征; 杨田野1; 刘光辉2; 孟春1
福建中医药大学附属人民医院（福州 350004）
Author(s):
ZHENG Yongzheng;  YANG Tianye;  LIU Guanghui;  MENG Chun
People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine，Fuzhou，Fujian 350004, China
关键词:
血管内皮细胞; 糖尿病; 酪氨酸激酶受体1; 血管内皮生长因子; 基质金属蛋白酶
Keywords:
vascular endothelial cells;  diabetes;  Tie1;  vascular endothelial growth factor;  matrix metalloproteinase
分类号:
R587.1
文献标志码:
A
摘要:
目的 探讨酪氨酸激酶受体1短发夹RNA（Tie1-shRNA）对高糖培养的大鼠内皮细胞（rECs）Tie1的表达的影响。 方法 将rECs分为对照组、高糖组、高糖+慢病毒组和高糖+Tie1-shRNA组4组。构建Tie1-shRNA慢病毒载体，作用于高糖培养的rECs，干扰酪氨酸激酶受体1（Tie1）mRNA的表达；采用MTT法检测细胞增殖情况，细胞划痕实验检测细胞迁移情况，Western blot检测rECs中Tie1、血管内皮生长因子-A（VEGF-A）、基质金属蛋白酶-2（MMP-2）和基质金属蛋白酶-9（MMP-9）的蛋白表达。 结果 细胞增殖活性4组间差异有统计学意义（F=48.937，P<0.01），其中高糖组细胞增殖活性明显高于对照组（P<0.01），高糖+Tie1-shRNA组细胞增殖活性较高糖组和高糖+慢病毒组均明显减弱（均P<0.01）。细胞迁移率4组间差异有统计学意义（F=26.728，P<0.01），其中高糖组细胞迁移率比对照组明显增加（P<0.01），高糖+Tie1-shRNA组细胞迁移率较高糖组和高糖+慢病毒组均明显减弱（均P<0.05）。4组rECs的Tie1、VEGF-A、MMP-2、MMP-9蛋白的表达差异有统计学意义（FTie1=85.902，P<0.01；FVEGF-A=48.937， P<0.01；FMMP-2=169.857，P<0.01；FMMP-9=130.018，P<0.01），其中高糖组rECs的Tie1、VEGF-A、MMP-2、MMP-9蛋白的表达明显高于对照组（均P<0.05），高糖+Tie1-shRNA组rECs的Tie1、VEGF-A、MMP-2、MMP-9蛋白的表达较高糖组和高糖+慢病毒组均明显降低（均P<0.05）。 结论 通过Tie1-shRNA技术抑制高糖培养的rEC中Tie1的表达，可下调VEGF-A、MMP-2、MMP-9蛋白的表达，减轻高糖诱导的rEC的增殖和迁移。
Abstract:
Objective To investigate the effect of Tie1-shRNA on the expression of tie1 in high glucose cultured rat endothelial cell（rECs）．Methods rECs were divided into four groups：control group, high glucose group, high glucose + lentivirus group and high glucose + Tie1-shRNA group．Tie1-shRNA lentiviral vector was constructed and used to interfere the expression of Tie1 mRNA in high glucose cultured rECs．The viability of rEC was detected by MTT, the migration of rEC was detected by cell scratch tests, and the expressions of Tie1, VEGF-A, MMP2 and MMP-9 were detected by Western blot．Results The difference of cell viability among the four groups was statistically significant (F=48.937, P<0.01).The cell viability of high glucose group was significantly higher than that of control group (P<0.01)．The cell viability of high glucose + Tie1-shRNA group was lower than that of high glucose group and high glucose + lentivirus group (both P<0.01)．The difference of cell migration rate among the four groups was statistically significant (F=26.728, P<0.01)．The cell migration rate of high glucose group was significantly higher than that of control group (P<0.01), and the cell migration rate of high glucose + Tie1-shRNA group was significantly lower than that of high glucose group and high glucose + lentivirus group (both P<0.05)．The differences of the expression of Tie1, VEGF-A, MMP-2 and MMP-9 protein among the four groups were statistically significant (FTie1=85.902, P<0.01; FVEGF-A=48.937, P<0.01; FMMP-2=169.857, P<0.01; FMMP-9=130.018, P<0.01)．The expression of Tie1, VEGF-A, MMP-2 and MMP-9 protein of high glucose group were significantly higher than those of control group (all P<0.05).The expression of Tie1, VEGF-A, MMP-2 and MMP-9 protein in high glucose + Tie1-shRNA group were significantly lower than those in high glucose + lentivirus group and high glucose group (all P<0.05)．Conclusion Tie1-shRNA can decrease the expression of Tie1, VEGF-A, MMP-2 and MMP-9, suppress cell viability and cell migration induced by high glucose.

参考文献/References:

[1]Solanki A,Bhatt L K,Johnston T P,et al．Targeting Matrix Metalloproteinases for Diabetic Retinopathy：The Way Ahead?[J]．Curr Protein Pept Sci,2019,20(4):324-333.
[2]Patel J I,Hykin P G,Gregor Z J,et al．Angiopoietin concentrations in diabetic retinopathy[J]．Br J Ophthalmol,2005,89(4):480-483.
[3]Cai J,Kehoe O,Smith G M,et al．The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy[J]．Invest Ophthalmol Vis Sci,2008,49(5):2163-2171.
[4]Khan M,Aziz A A,Shafi N A,et al．Targeting Angiopoietin in Retinal Vascular Diseases：A Literature Review and Summary of Clinical Trials Involving Faricimab[J]．Cells,2020,9(8):1869.
[5]Pang B,Ni Q,Di S,et al．Luo Tong Formula Alleviates Diabetic Retinopathy in Rats Through Micro-200b Target[J]．Front Pharmacol,2020,11:551766.
[6]林翠红,刘光辉,杨田野,等．大鼠主动脉内皮细胞改良型分离培养方法[J]．西安交通大学学报（医学版）,2018,39(6):911-916.
[7]Heng L Z,Comyn O,Peto T,et al．Diabetic retinopathy：pathogenesis,clinical grading,management and future developments[J]．Diabet Med,2013,30(6):640-650.
[8]Antonetti D A,Barber A J,Hollinger L A,et al．Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1．A potential mechanism for vascular permeability in diabetic retinopathy and tumors[J]．J Biol Chem,1999,274(33):23463-23467.
[9]Witmer A N,Vrensen G F,Van Noorden C J,et al．Vascular endothelial growth factors and angiogenesis in eye disease[J]．Prog Retin Eye Res,2003,22(1):1-29.
[10]Hamilton N B,Attwell D,Hall C N．Pericyte-mediated regulation of capillary diameter：a component of neurovascular coupling in health and disease[J]．Front Neuroenergetics,2010,21(2):5.
[11]Rodrigues M,Xin X,Jee K,et al．VEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy[J]．Diabetes,2013,62(11):3863-3873.
[12]Pepper M S．Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis[J]．Arterioscler Thromb Vasc Biol,2001,21(7):1104-1117.
[13]Abu EAM,Mohammad G,Nawaz M I,et al．Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy[J]．PLoS One,2013,8(12):e85857.
[14]Marron M B,Hughes D P,Edge M D,et al．Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2[J]．J Biol Chem,2000,275(50):39741-39746.
[15]Kaur J,Adya R,Tan B K,et al．Identification of chemerin receptor (ChemR23) in human endothelial cells：chemerin-induced endothelial angiogenesis[J]．Biochem Biophys Res Commun,2010,391(4):1762-1768.
[16]Yao J S,Chen Y,Zhai W,et al．Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration：the role of ERK1/2,PI3K,and matrix metalloproteinases[J]．Circ Res,2004,95(4):364-371.
[17]Ma Y,Dong C,Chen X,et al．Silencing of miR-20b-5p Exerts Inhibitory Effect on Diabetic Retinopathy via Inactivation of THBS1 Gene Induced VEGF/Akt/PI3K Pathway[J]．Diabetes Metab Syndr Obes,2021,16(14):1183-1193.
[18]Bilimoria J,Singh H．The Angiopoietin ligands and Tie receptors：potential diagnostic biomarkers of vascular disease[J]．J Recept Signal Transduct Res,2019,39(3):187-193.
[19]La Porta S,Roth L,Singhal M,et al．Endothelial Tie1-mediated angiogenesis and vascular abnormalization promote tumor progression and metastasis[J]．J Clin Invest,2018,128(2):834-845.

相似文献/References:

[1]刘云路 陈刚.药物引起的糖尿病及高血糖症研究进展[J].福建医药杂志,2017,39(5):1.
[2]熊红萍 徐 静 周 强 吴埼淇 甘国翔 陈忠山.盐酸小檗碱对糖尿病患者血糖、胃肠激素及肠道菌群的影响[J].福建医药杂志,2019,41(01):6.
　XIONG Hongping,XV Jing,ZHOU Qiang,et al.Effect of berberine on blood glucose,gastrointestinal hormones and intestinal flora of diabetic patients[J].FUJIAN MEDICAL JOURNAL,2019,41(04):6.
[3]查小云 魏长顺 赖鹏斌.胰腺纤维钙化性糖尿病16例临床特点分析并文献复习[J].福建医药杂志,2020,42(04):14.
　ZHA Xiaoyun,WEI Changshun,LAI Pengbin..Analysis of clinical characteristics of 16 cases with fibrocalculous pancreatic diabetes and literature review[J].FUJIAN MEDICAL JOURNAL,2020,42(04):14.
[4]陈妍,林娟,杨曼华,等.认知负荷理论干预老年T2DM患者饮食控制的效果及影响因素分析[J].福建医药杂志,2021,43(04):14.
[5]许雪峰,陈彦,赵洁馨,等.幽门螺杆菌感染与非酒精性脂肪性肝病的关系探讨[J].福建医药杂志,2022,44(04):8.
　XU Xuefeng,CHEN Yan,ZHAO Jiexin,et al.Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease[J].FUJIAN MEDICAL JOURNAL,2022,44(04):8.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金资助项目（81774369）；福建省自然科学基金资助项目（2020J011037）
1 福州大学生物科学与工程学院；2 通信作者, Email：latiny@gmail.com
更新日期/Last Update: 2021-08-15